Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB110353

CD83 Antibody (104), Biotin, Novus Biologicals™
SDP

Catalog No. NB110353 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB110353 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB110353 Supplier Novus Biologicals Supplier No. NBP289980B
Only null left
Add to Cart
Add to Cart

Description

Rabbit Monoclonal Antibody

CD83 Monoclonal specifically detects CD83 in Human samples. It is validated for Western Blot.

Specifications

Antigen CD83
Applications Western Blot
Classification Monoclonal
Clone 104
Conjugate Biotin
Formulation PBS
Gene Alias B-cell activation protein, BL11CD83 antigen, CD83 antigen (activated B lymphocytes, immunoglobulin superfamily), CD83 molecule, Cell surface protein HB15, cell-surface glycoprotein, HB15hCD83
Host Species Rabbit
Immunogen This antibody was obtained from a rabbit immunized with purified, recombinant Human CD83 (Q01151-1; Met1-Ala143).
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Dendritic Cell Markers
Primary or Secondary Primary
Gene ID (Entrez) 9308
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.